Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             150 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abdominal Imaging in pregnancy (maternal and foetal risks) Flanagan, Emma

48-49 C p.
artikel
2 Acute severe ulcerative colitis: State of the art treatment Gisbert, Javier P.
2018
48-49 C p. 59-69
artikel
3 Alcohol and other substance use after liver transplant Winder, Gerald Scott

48-49 C p.
artikel
4 An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management Smith, Padraic

48-49 C p.
artikel
5 Artificial Intelligence for gastrointestinal endoscopy: When technology meets our needs! Hassan, Cesare

48-49 C p.
artikel
6 Artificial intelligence in biliopancreatic endoscopy: Is there any role? Ahmad, Omer F.

48-49 C p.
artikel
7 Artificial intelligence: Thinking outside the box Tontini, Gian Eugenio

48-49 C p.
artikel
8 Barrett esophagus: What to expect from Artificial Intelligence? Ebigbo, Alanna

48-49 C p.
artikel
9 Biosimilars in ulcerative colitis: When and for who? Ilias, Akos
2018
48-49 C p. 35-42
artikel
10 Can IL-23 be a good target for ulcerative colitis? Allocca, Mariangela
2018
48-49 C p. 95-102
artikel
11 “Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?” Varyani, Fumi
2019
48-49 C p.
artikel
12 Can we move directly from 5-ASA to a biologic agent in ulcerative colitis? Hindryckx, Pieter
2018
48-49 C p. 9-15
artikel
13 Cardiovascular and metabolic disease in the liver transplant recipient Kim, Nathan G.

48-49 C p.
artikel
14 Changes to gastrointestinal function after surgery for colorectal cancer Lam, David

48-49 C p.
artikel
15 Changing epidemiology and etiology of upper and lower gastrointestinal bleeding Oakland, Kathryn

48-49 C p.
artikel
16 Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer van den Ende, Tom
2018
48-49 C p. 45-52
artikel
17 Chronic diarrhoea in an oncology patient – Clinical assessment and decision making Fernandes, Darren CR.

48-49 C p.
artikel
18 Colorectal cancer prevention in patients with ulcerative colitis Lopez, Anthony
2018
48-49 C p. 103-109
artikel
19 Colorectal polyp characterization with endocytoscopy: Ready for widespread implementation with artificial intelligence? Barua, Ishita

48-49 C p.
artikel
20 Colorectal polyp characterization with standard endoscopy: Will Artificial Intelligence succeed where human eyes failed? Parsa, Nasim

48-49 C p.
artikel
21 Copyright Information
48-49 C p.
artikel
22 Copyright Information
48-49 C p.
artikel
23 Cost-effectiveness of prevention and early detection of gastric cancer in Western countries Lansdorp-Vogelaar, Iris

48-49 C p.
artikel
24 De novo and recurrent liver disease Ip, Stephen

48-49 C p.
artikel
25 De novo and recurrent malignancy Shalaby, Sarah

48-49 C p.
artikel
26 Detection of flat colorectal neoplasia by artificial intelligence: A systematic review Yamada, Masayoshi

48-49 C p.
artikel
27 Early detection of gastric cancer beyond endoscopy - new methods Leja, Mārcis

48-49 C p.
artikel
28 Early gastric cancer and Artificial Intelligence: Is it time for population screening? Arribas Anta, Julia

48-49 C p.
artikel
29 Editorial Board 2018
48-49 C p. ii
artikel
30 Editorial Board 2018
48-49 C p. ii
artikel
31 Editorial Board 2018
48-49 C p. ii
artikel
32 Editorial Board 2019
48-49 C p.
artikel
33 Editorial Board 2019
48-49 C p.
artikel
34 Editorial Board
48-49 C p.
artikel
35 Editorial Board
48-49 C p.
artikel
36 Editorial Board
48-49 C p.
artikel
37 Editorial Board
48-49 C p.
artikel
38 Editorial Board
48-49 C p.
artikel
39 Editorial Board
48-49 C p.
artikel
40 Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease Wieringa, J.W.

48-49 C p.
artikel
41 Effect of frequently prescribed drugs on gastric cancer risk Weltermann, Theresa

48-49 C p.
artikel
42 Endoscopic management of dysplasia and early oesophageal cancer Zeki, S.S.
2018
48-49 C p. 27-36
artikel
43 Endoscopic management of nonvariceal upper gastrointestinal bleeding Cañamares-Orbís, Pablo

48-49 C p.
artikel
44 Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease Hart, Lara
2019
48-49 C p.
artikel
45 Esophageal squamous dysplasia and cancer: Is artificial intelligence our best weapon? Hussein, Mohamed

48-49 C p.
artikel
46 Evolution of our understanding of PBC Tanaka, Atsushi
2018
48-49 C p. 3-9
artikel
47 Evolution of treatment targets in Crohn’s disease White, Jonathan R.
2019
48-49 C p.
artikel
48 Evolving strategies and goals of treatment in ulcerative colitis Allocca, Mariangela
2018
48-49 C p. 1-2
artikel
49 Follow-up of liver transplant recipients Neuberger, James

48-49 C p.
artikel
50 Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) – A Helicobacter-opposite point Tacheci, Ilja

48-49 C p.
artikel
51 Gastric cancer- endoscopic treatment of early lesions, the West learns from the East Prinz, Friederike

48-49 C p.
artikel
52 Gastrointestinal side effects of upper gastrointestinal cancer surgery Antonowicz, S.

48-49 C p.
artikel
53 Geoepidemiology and (epi-)genetics in primary biliary cholangitis Roberto, Rosa
2018
48-49 C p. 11-15
artikel
54 Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit Koletzko, Leandra
2019
48-49 C p.
artikel
55 Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have? Link, Alexander

48-49 C p.
artikel
56 IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease? Ma, Christopher
2019
48-49 C p.
artikel
57 Immunosuppression in liver transplant Di Maira, Tommaso

48-49 C p.
artikel
58 Immunotherapy induced enterocolitis and gastritis – What to do and when? Cheung, Vincent Ting Fung

48-49 C p.
artikel
59 Impact of artificial intelligence on colorectal polyp detection Antonelli, Giulio

48-49 C p.
artikel
60 Impact of gastric cancer treatment on quality of life of patients Schütte, Kerstin

48-49 C p.
artikel
61 Improving prognosis in primary biliary cholangitis – Therapeutic options and strategy Harms, Maren H.
2018
48-49 C p. 85-94
artikel
62 Interfering with leukocyte trafficking in Crohn's disease Biswas, Sujata
2019
48-49 C p.
artikel
63 In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn's disease Meserve, Joseph
2019
48-49 C p.
artikel
64 Introduction to care of the liver transplant recipient Neuberger, James M.

48-49 C p.
artikel
65 Is PBC a viral infectious disease? Mason, Andrew L.
2018
48-49 C p. 27-39
artikel
66 Is there still a role for the surgeon in the management of gastrointestinal bleeding ? Donohoe, Claire L.

48-49 C p.
artikel
67 JAK inhibitors: Novel developments in management of ulcerative colitis Fiorino, Gionata
2018
48-49 C p. 89-93
artikel
68 Molecular modelling of the gastric barrier response, from infection to carcinogenesis Traulsen, Jan

48-49 C p.
artikel
69 Molecular pathways in the development and treatment of oesophageal cancer Walker, Robert Charles
2018
48-49 C p. 9-15
artikel
70 Multi-modal and sequential treatment of liver cancer and its impact on the gastrointestinal tract Seidensticker, Max

48-49 C p.
artikel
71 Neoadjuvant chemoradiotherapy for resectable oesophageal cancer Eyck, B.M.
2018
48-49 C p. 37-44
artikel
72 Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils Singh, Siddharth
2019
48-49 C p.
artikel
73 Non-adherence and transition clinics Kelly, Deirdre

48-49 C p.
artikel
74 Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery) Arkenbosch, J.H.C.

48-49 C p.
artikel
75 Novel imaging techniques in staging oesophageal cancer Foley, Kieran
2018
48-49 C p. 17-25
artikel
76 Nutrition and gastroenterological support in end of life care Schütte, Kerstin

48-49 C p.
artikel
77 Oesophagectomy: The expanding role of minimally invasive surgery in oesophageal cancer van den Berg, J.W.
2018
48-49 C p. 75-80
artikel
78 Optimal management of the patient presenting with small bowel bleeding Sey, Michael Sai Lai

48-49 C p.
artikel
79 Optimal timing of endoscopy in patients with acute upper gastrointestinal bleeding Chaudhary, Sardar

48-49 C p.
artikel
80 Overcoming barriers to implementation of artificial intelligence in gastroenterology Sutton, Richard A.

48-49 C p.
artikel
81 Palliation of dysphagia van der Bogt, R.D.
2018
48-49 C p. 97-103
artikel
82 Pathophysiology of primary biliary cholangitis Gulamhusein, Aliya F.
2018
48-49 C p. 17-25
artikel
83 Pathophysiology of the irritable bowel syndrome – Reflections of today Hellström, Per M.
2019
48-49 C p.
artikel
84 Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC) Janmohamed, Ashnila
2018
48-49 C p. 71-83
artikel
85 PBC and related extrahepatic diseases Floreani, Annarosa
2018
48-49 C p. 49-54
artikel
86 PBC-transplantation and disease recurrence Nevens, Frederik
2018
48-49 C p. 107-111
artikel
87 Peri-operative patient optimization for oesophageal cancer surgery – From prehabilitation to enhanced recovery Zylstra, J.
2018
48-49 C p. 61-73
artikel
88 Pharmacology, efficacy and safety of JAK inhibitors in Crohn’s disease Ma, Christopher
2019
48-49 C p.
artikel
89 Pitfalls in training and validation of deep learning systems Eelbode, Tom

48-49 C p.
artikel
90 Post liver transplant recurrent and de novo viral infections Jothimani, Dinesh

48-49 C p.
artikel
91 Preconception counseling of females with inflammatory bowel disease Rottenstreich, Amihai

48-49 C p.
artikel
92 Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation Milić, Sandra

48-49 C p.
artikel
93 Preface - Evolving approaches to the evaluation and management of Crohn’s disease Jairath, Vipul
2019
48-49 C p.
artikel
94 Preface - Functional gastrointestinal disorders Hellström, Per M.
2019
48-49 C p.
artikel
95 Preface – Gastrointestinal bleeding Jairath, Vipul

48-49 C p.
artikel
96 Preface “Oesophageal cancer” Wijnhoven, Bas
2018
48-49 C p. 1
artikel
97 Preface: Pregnancy in GI-disorders Van der Woude, C.J.

48-49 C p.
artikel
98 Preface - Primary Biliary Cholangitis van Buuren, Henk R.
2018
48-49 C p. 1
artikel
99 Primary biliary cholangitis and bone disease Parés, Albert
2018
48-49 C p. 63-70
artikel
100 Progress in the treatment of cancer patients – don’t forget the gut feeling! Bornschein, Jan

48-49 C p.
artikel
101 Proton pump inhibitors for upper gastrointestinal bleeding Kherad, Omar

48-49 C p.
artikel
102 Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome Lindberg, Greger
2019
48-49 C p.
artikel
103 Publisher's note Wetherell, Victoria
2019
48-49 C p.
artikel
104 Quality of life after liver transplantation Åberg, Fredrik

48-49 C p.
artikel
105 Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options Araujo, Isis K.

48-49 C p.
artikel
106 Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options Afifi, Ahmed N.A.M.

48-49 C p.
artikel
107 Recent progress in gastric cancer prevention Park, Jin Young

48-49 C p.
artikel
108 Recent progress in the understanding of gastric cancer – Do patients experience a benefit yet? Bornschein, Jan

48-49 C p.
artikel
109 Reflux esophagitis, functional and non-functional Bor, Serhat
2019
48-49 C p.
artikel
110 Refractory ulcerative proctitis: How to treat it? Pineton de Chambrun, Guillaume
2018
48-49 C p. 49-57
artikel
111 Renal disease in the allograft recipient Nevens, Frederik

48-49 C p.
artikel
112 Risk factors for oesophageal cancer Xie, Shao-Hua
2018
48-49 C p. 3-8
artikel
113 Risk stratification and prognostic modelling in primary biliary cholangitis Goet, Jorn C.
2018
48-49 C p. 95-106
artikel
114 Risk stratification in upper and upper and lower GI bleeding: Which scores should we use? Oakland, Kathryn

48-49 C p.
artikel
115 Robot assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer van der Sluis, Pieter Christiaan
2018
48-49 C p. 81-83
artikel
116 Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses Bonovas, Stefanos
2018
48-49 C p. 43-47
artikel
117 Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis? Pouillon, Lieven
2018
48-49 C p. 17-25
artikel
118 Should we use vedolizumab as mono or combo therapy in ulcerative colitis? Hedin, Charlotte
2018
48-49 C p. 27-34
artikel
119 Small Bowel Capsule Endoscopy and artificial intelligence: First or second reader? Piccirelli, Stefania

48-49 C p.
artikel
120 Striving for quality improvement: can artificial intelligence help? Sinonquel, P.

48-49 C p.
artikel
121 Surgery in ulcerative colitis: When? How? Gallo, Gaetano
2018
48-49 C p. 71-78
artikel
122 Symptoms of PBC – Pathophysiology and management Khanna, Amardeep
2018
48-49 C p. 41-47
artikel
123 Table of Contents
48-49 C p.
artikel
124 Table of Contents
48-49 C p.
artikel
125 Tangible pathologies in functional dyspepsia Walker, Marjorie M.
2019
48-49 C p.
artikel
126 Targeted and immunotherapy in the era of personalised gastric cancer treatment Catanese, Silvia

48-49 C p.
artikel
127 Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier? Ma, Christopher
2019
48-49 C p.
artikel
128 Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future Webb, Dominic-Luc
2019
48-49 C p.
artikel
129 The complexity of cancer origins at the gastro-oesophageal junction Bornschein, Jan

48-49 C p.
artikel
130 The immune system and microbiome in pregnancy Fuhler, G.M.

48-49 C p.
artikel
131 The impact of biologics in surgical outcomes in ulcerative colitis Argollo, Marjorie C.
2018
48-49 C p. 79-87
artikel
132 The impact of modulating the gastrointestinal microbiota in cancer patients Morkūnas, Egidijus

48-49 C p.
artikel
133 The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease Picardo, Sherman

48-49 C p.
artikel
134 The impact of recent next generation sequencing and the need for a new classification in gastric cancer Businello, Gianluca

48-49 C p.
artikel
135 The influence of the gastric microbiota in gastric cancer development Pereira-Marques, Joana

48-49 C p.
artikel
136 The interpretation of liver function tests in pregnancy Guarino, Maria

48-49 C p.
artikel
137 The management of mid & proximal oesophageal squamous cell carcinoma Wong, Ian
2018
48-49 C p. 85-90
artikel
138 The optimal use of blood components in the management of gastrointestinal bleeding Donovan, Killian

48-49 C p.
artikel
139 The pros and cons of gastric bypass surgery – The role of the Roux-limb Björklund, Per
2019
48-49 C p.
artikel
140 Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS Benno, P.
2019
48-49 C p.
artikel
141 The role of colonoscopy and endotherapy in the management of lower gastrointestinal bleeding Sengupta, Neil

48-49 C p.
artikel
142 The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer Jeene, Paul M.
2018
48-49 C p. 53-59
artikel
143 The role of surgery in advanced disease for esophageal and junctional cancer Mönig, Stefan
2018
48-49 C p. 91-96
artikel
144 The Rome IV: Irritable bowel syndrome - A functional disorder Hellström, Per M.
2019
48-49 C p.
artikel
145 Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders Al-Saffar, Ahmad
2019
48-49 C p.
artikel
146 Variant syndromes of primary biliary cholangitis Schulz, Lisa
2018
48-49 C p. 55-61
artikel
147 What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity? Ma, Christopher
2019
48-49 C p.
artikel
148 What is the role of histopathology in the evaluation of disease activity in Crohn's disease? Pai, Rish K.
2019
48-49 C p.
artikel
149 When all else fails - Radiological management of severe gastrointestinal bleeding Loffroy, Romaric

48-49 C p.
artikel
150 Which evidence for a treat to target strategy in ulcerative colitis? Marchal Bressenot, Aude
2018
48-49 C p. 3-8
artikel
                             150 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland